What Would You Do? Exploring the Role of Genetic Testing in the Diagnosis and Management of Late Onset Alzheimer’s Disease
Webcast
0.5 CME ...OVERVIEW
What Would You Do? Exploring the Role of Genetic Testing in the Diagnosis and Management of Late Onset Alzheimer’s Disease is organized by Healio, Catamount Medical Education.
Release Date: July 31, 2023
Expiration Date: July 31, 2024
Learning Objectives:
Upon completion of this activity, participants should be able to:
• Review advances in understanding of genetic risk factors underlying late-onset AD
• Assess benefits and limitations in the use of genetic testing for screening/diagnosis
• Discuss strategies for educating and counseling patients and caregivers regarding the implications of genetic test results
• Utilize best practices for patient selection for genetic screening
• Discuss best practices for ordering genetic tests and interpreting the results
ACCREDITATION & CREDITS
Accreditation:
Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Catamount Medical Education. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation:
Physician Continuing Education:
PACE designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education:
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.
PA Continuing Medical Education:
PACE has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned following AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until July 31, 2024. PAs should only claim credit commensurate with the extent of their participation.
All other healthcare professionals completing this course will be stated participation.
TARGET AUDIENCE
PhysicianNeurologistsFamily MedicineInternal MedicineGeriatricsPsychiatristsNurse PractitionersSPECIALITIES
Neurology
Quick Links